US2021299274A1PendingUtilityA1

Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor

Assignee: UNIV PENNSYLVANIAPriority: Sep 30, 2003Filed: Apr 7, 2021Published: Sep 30, 2021
Est. expirySep 30, 2023(expired)· nominal 20-yr term from priority
C07K 14/005C12N 9/644C12Y 304/21022C12N 2750/14142C12N 2830/85C07K 14/705C12N 2830/48C12N 2830/008C12N 2750/14151A61K 48/00A61P 43/00C12N 15/86C12N 2750/14143C12N 2750/14121C12N 2750/14122C12N 7/00
80
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Sequences of novel adeno-associated virus capsids and vectors and host cells containing these sequences are provided. Also described are methods of using such host cells and vectors in production of rAAV particles. AAV-mediated delivery of therapeutic and immunogenic genes using the vectors of the invention is also provided.

Claims

exact text as granted — not AI-modified
1 . A protein comprising an AAV9/HU.14 protein or a fragment thereof selected from the group consisting of:
 (a) an AAV9/HU.14 capsid protein or fragment thereof, selected from the group consisting of:
 vp1 capsid protein, amino acids (aa) 1 to 736, SEQ ID NO:123; 
 vp2 capsid protein, aa 138 to 736, SEQ ID NO: 123; 
 vp3 capsid protein, aa 203 to 736, SEQ ID NO: 123; 
 wherein the amino acid numbers are those of the AAV2 capsid, SEQ ID NO:4 and corresponding regions in the capsid of AAV9/HU.14, SEQ ID NO:123.

Join the waitlist — get patent alerts

Track US2021299274A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.